Actualités id6343.html
In development: Guidance, quality standards and advice
Sun, 26 Jan 2025 10:37:00 GMT
Hydromethylthionine mesylate for treating mild cognitive impairment or mild or moderate dementia caused by Alzheimer's disease [ID6343] Technology appraisal guidance TBC Ibrutinib for treating ...